Eli Lilly
LLY
4,631 hedge funds and large institutions have $899B invested in Eli Lilly in 2026 Q3 according to their latest regulatory filings, with 212 funds opening new positions, 2,232 increasing their positions, 1,623 reducing their positions, and 145 closing their positions.
46% more first-time investments, than exits
New positions opened: 212 | Existing positions closed: 145
38% more repeat investments, than reductions
Existing positions increased: 2,232 | Existing positions reduced: 1,623
1% less funds holding
Funds holding: 4,673 → 4,631 (-42)
5% less call options, than puts
Call options by funds: $17B | Put options by funds: $18B
1.6% less ownership
Funds ownership: 84.13% → 82.53% (-1.6%)
6% less funds holding in top 10
Funds holding in top 10: 478 → 448 (-30)
27% less capital inflows, than outflows
Capital inflows: $27.8B | Capital outflows: $38.2B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.77B |
| 2 |
JP Morgan Chase
New York
|
+$1.4B |
| 3 |
UBS AM
Chicago,
Illinois
|
+$1.38B |
| 4 |
CTC (Chicago Trading Company)
Chicago,
Illinois
|
+$1.06B |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$896M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.4B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$4.57B |
| 3 |
Goldman Sachs
New York
|
-$937M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$830M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$624M |
LLY Hedge Fund Activity: Q3 2026 in Review
4,631 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q3 2026, worth a combined $899B — down 5.2% from $949B a quarter earlier.
Buyers outnumbered sellers: 212 funds opened new LLY positions and 145 closed out — a net gain of 67 holders — while 2,232 added to existing stakes and 1,623 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $1.77B. The largest seller was Royal Bank of Canada, cutting an estimated $5.4B.
- 4,631 institutional investors held Eli Lilly (LLY) as of Q3 2026, down from 4,673 in Q2 2026.
- Funds reported $899B of Eli Lilly stock for Q3 2026, down 5.2% quarter-over-quarter.
- 212 funds opened new Eli Lilly positions in Q3 2026 and 145 closed out, a net change of +67 holders.
- The largest Eli Lilly buyer in Q3 2026 was Fidelity Investments, an estimated $1.77B added.
- The largest Eli Lilly seller in Q3 2026 was Royal Bank of Canada, an estimated $5.4B sold.
Based on aggregated 13F filings for Q3 2026.